Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Dec 15, 2025, 9:30 AM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $912.58 thousand as of December 16, 2025. Its market cap has increased by 7,099.87% in one year.
Market Cap
912.58K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 912.58K, a decrease of -99.96%. That is a compound annual growth rate of -84.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 912.58K | 44.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |